(Updated - April 22, 2024 7:19 AM EDT)

Oppenheimer analyst Jeff Jones initiates coverage on Kymera Therapeutics (NASDAQ: KYMR) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE